X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (460) 460
venlafaxine hydrochloride (390) 390
male (357) 357
pharmacology & pharmacy (317) 317
cyclohexanols - pharmacokinetics (282) 282
female (273) 273
index medicus (269) 269
animals (261) 261
venlafaxine (232) 232
adult (206) 206
cyclohexanols - pharmacology (196) 196
psychiatry (169) 169
cyclohexanols - therapeutic use (162) 162
antidepressants (140) 140
cyclohexanols - administration & dosage (140) 140
rats (135) 135
neurosciences (126) 126
cyclohexanols - adverse effects (123) 123
middle aged (123) 123
pharmacokinetics (107) 107
cyclohexanols - blood (98) 98
dose-response relationship, drug (97) 97
desvenlafaxine succinate (95) 95
drug interactions (94) 94
mice (86) 86
serotonin uptake inhibitors - pharmacokinetics (81) 81
antidepressive agents, second-generation - pharmacokinetics (79) 79
antidepressive agents, second-generation - therapeutic use (78) 78
cyclohexanols - chemistry (74) 74
in-vitro (74) 74
depression (72) 72
depressive disorder, major - drug therapy (71) 71
serotonin uptake inhibitors - therapeutic use (71) 71
aged (70) 70
antidepressant (64) 64
clinical neurology (63) 63
depressive disorder - drug therapy (63) 63
fluoxetine (61) 61
serotonin uptake inhibitors - pharmacology (59) 59
antidepressive agents, second-generation - adverse effects (57) 57
double-blind (54) 54
rats, sprague-dawley (53) 53
serotonin uptake inhibitors - adverse effects (53) 53
metabolites (52) 52
antidepressive agents - therapeutic use (51) 51
cyp2d6 (51) 51
analysis (50) 50
brain - metabolism (49) 49
cyclohexanols - metabolism (49) 49
treatment outcome (49) 49
adolescent (48) 48
major depression (48) 48
serotonin reuptake inhibitors (47) 47
drugs (46) 46
serotonin (46) 46
time factors (46) 46
toxicology (46) 46
antidepressive agents, second-generation - administration & dosage (45) 45
metabolism (45) 45
rats, wistar (45) 45
antidepressive agents - pharmacokinetics (43) 43
double-blind method (43) 43
antidepressive agents, second-generation - pharmacology (42) 42
cytochrome p-450 cyp2d6 - genetics (42) 42
antidepressive agents - pharmacology (40) 40
in vitro techniques (40) 40
paroxetine (40) 40
area under curve (38) 38
efficacy (37) 37
genotype (37) 37
administration, oral (36) 36
drug therapy (36) 36
major depressive disorder (36) 36
young adult (36) 36
antidepressive agents - adverse effects (35) 35
cytochrome p-450 cyp2d6 - metabolism (35) 35
antidepressive agents, second-generation - blood (34) 34
pharmacology (34) 34
drug therapy, combination (32) 32
dosage and administration (31) 31
serotonin uptake inhibitors - administration & dosage (31) 31
antidepressive agents - administration & dosage (30) 30
brain - drug effects (30) 30
cross-over studies (30) 30
desvenlafaxine (30) 30
chemistry, analytical (29) 29
chemistry, medicinal (29) 29
delayed-action preparations (29) 29
depression - drug therapy (29) 29
brain (28) 28
disease models, animal (28) 28
motor activity - drug effects (28) 28
rat-brain (28) 28
analysis of variance (27) 27
stereoisomerism (27) 27
depression, mental (26) 26
drug administration schedule (26) 26
pharmacology/toxicology (26) 26
reproducibility of results (26) 26
biochemistry & molecular biology (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Breath Research, ISSN 1752-7155, 12/2013, Volume 7, Issue 4, p. 046008
Journal Article
Journal of Psychiatric Research, ISSN 0022-3956, 2013, Volume 48, Issue 1, pp. 1 - 12
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 05/2004, Volume 161, Issue 5, pp. 826 - 835
Journal Article
Environmental Toxicology and Chemistry, ISSN 0730-7268, 08/2012, Volume 31, Issue 8, pp. 1831 - 1837
Journal Article
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 12/2009, Volume 70, Issue 12, pp. 1688 - 1697
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2013, Volume 168, Issue 6, pp. 1506 - 1518
Background The SH2-containing inositol-5-phosphatase 1 (SHIP1) metabolizes PI(3,4,5)P3 to PI(3,4)P2. SHIP1-deficient mice exhibit progressive inflammation.... 
cell motility | phosphatidylinositol | PI3K | inflammation | SHIP1 | pulmonary | chemotaxis | PHASE | PHOSPHORYLATION | KINASE | PHARMACOLOGY & PHARMACY | T-LYMPHOCYTES | Enzyme Activators - pharmacology | Humans | Inositol Polyphosphate 5-Phosphatases | Male | Isoenzymes - chemistry | Spleen - drug effects | Anti-Inflammatory Agents, Non-Steroidal - blood | Chemotaxis, Leukocyte - drug effects | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Cyclohexanols - pharmacology | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Recombinant Proteins - antagonists & inhibitors | Isoenzymes - genetics | Indans - metabolism | Rats | Recombinant Proteins - chemistry | Spleen - cytology | Rats, Sprague-Dawley | Cyclohexanols - blood | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Mast Cells - secretion | Mice | Enzyme Activators - pharmacokinetics | Indans - pharmacokinetics | Cyclohexanols - pharmacokinetics | Enzyme Activators - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Cyclohexanols - metabolism | Protein Processing, Post-Translational - drug effects | Isoenzymes - metabolism | Female | Indans - blood | Recombinant Proteins - metabolism | Cell Line | Phosphoric Monoester Hydrolases - genetics | Spleen - secretion | Mice, Inbred C57BL | Cells, Cultured | Enzyme Activators - blood | Mast Cells - drug effects | Animals | Spleen - metabolism | Dogs | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | Phosphoric Monoester Hydrolases - metabolism | Isoenzymes - antagonists & inhibitors | Indans - pharmacology | Phosphoric Monoester Hydrolases - chemistry
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 04/2010, Volume 24, Issue 4, pp. 537 - 546
Journal Article